Recent news on Liposomal

Doxil® Approved for Multiple Myeloma in Conjunction with Velcade®  -  25 May 2007
Cancer Consultants (press release),The US Food and Drug Administration (FDA) announced on May 17, 2007 the approval of Doxil (liposomal doxorubicin) plus Velcade for the treatment of patients

AUA 2007 - Multiple Investigations in Basic and Translational ...  -  25 May 2007
UroToday,Anai and associates reported on the administration of liposomal doxorubicin particles in a mouse model of bladder cancer [ABST 882].

Aradigm: Wall Street Analyst Forum Presentation Transcript  -  May 22, 2007
Seeking Alpha,There are a number of liposomal products now approved of the market. These are small vesicles made out of phospholipids that are constituents of our own

NEOPHARM, Inc. Announces First Quarter 2007 Financial Results  -  May 10, 2007
Genetic Engineering News (press release),...but not limited to the Company's ability to pursue additional testing of CINTREDEKIN BESUDOTOX and the liposomal technology drug product candidates

New Treatment For Fungi Which Cause Thrush And Sepsis  -  May 1, 2007
Medical News Today (press release),Researchers led by Oliver Cornely, of The University Hospital of Cologne, Germany, tested the effectiveness of two well known treatments, liposomal

Mycamine™ Equivalent to Ambisome® with Less Side Effects for ...  -  May 9, 2007
Cancer Consultants (press release),An international randomized trial has demonstrated that Mycamine (micafungin) is equivalent to Ambisome (liposomal amphotericin B) for the treatment of

New treatment targets thrush  -  Apr 26, 2007
InTheNews.co.uk,The drug – micafungin – was found to work as well as liposomal amphotericin B and caused fewer side effects, scientists report today in the online edition

Aradigm halves Q1 loss despite lower revenue  -  May 11, 2007
Bizjournals.com,...as well as towards putting our cystic fibrosis product candidate, liposomal ciprofloxacin, into the clinic within the next months."

Clinicares Expands Into the China Market  -  May 22, 2007
WM Experts (press release),These channels improve (1000 times) the penetration of the highest concentration of peptides, vitamin creams, or any other liposomal serums.

Ortho Biotech: extended Doxil approval unlikely to significantly ...  -  May 22, 2007
Pharmaceutical Business Review...'Content The FDA have approved the use of Ortho Biotech's Doxil (liposomal doxorubicin) in combination with Millennium Pharmaceuticals/Ortho Biotech's

Bacterially derived nanocells offer direct route for cancer therapy  -  May 16, 2007
BiopharmaReporter.com,16/05/2007 - Bacterially derived nanocells that can deliver chemotherapeutic drugs directly to cancer cells without the shortcomings of liposomal or viral

Velcade Plus Doxil Approved For Myeloma Treatment  -  May 22, 2007
eMaxHealth.com,Doxil is a specially (liposomal) formulated version of the chemotherapy agent doxorubicin, and is approved for use in other forms of cancer.

Intermediate-risk RCC patients diagram (Graphic: Business Wire)  -  May 21, 2007
Genetic Engineering News (press release),Aroplatin(TM) (L-NDDP), a liposomal, third-generation platinum chemotherapeutic; AG-707, a therapeutic vaccine for the treatment of genital herpes;

CybeRelease: (OTC: CCRC) Expands Their Laboratory Capability  -  May 2, 2007
WebWire (press release),These channels improve (1000 times) the penetration of the highest concentration of peptides, vitamin creams, or any other liposomal serums.

Algeta Presents Technology and Clinical Data at 17th International ...  -  Apr 27, 2007
PharmaLive.com (press release),In addition, a poster describing an Algeta-sponsored study investigating a novel liposomal technology for the targeted delivery of radium-223 will be

Micafungin Effective for Serious Candida Infections  -  26 Apr 2007
MedPage Today,Explain that this study concludes that micafungin (Mycamine) is as effective as liposomal amphotericin B (Ambisome) in treating these serious infections,

New treatment Candida fungi - fewer side effects  -  26 Apr 2007
News-Medical.net,Researchers led by Oliver Cornely, of The University Hospital of Cologne, Germany, tested the effectiveness of two well known treatments, liposomal

New treatment targets thrush  -  26 Apr 2007
InTheNews.co.uk,The drug – micafungin – was found to work as well as liposomal amphotericin B and caused fewer side effects, scientists report today in the online edition

Astellas Drug Is Less Risky Than Older Antifungal, Lancet Says  -  26 Apr 2007
BloombergAbout half were given micafungin, while the other half received AmBisome, also known as liposomal amphotericin B. Both treatments are administered through

Micafungin as Effective as Liposomal Amphotericin B in Children ...  -  Apr 2, 2007
DG News..."The overall treatment success rates were high and comparable for micafungin and liposomal amphotericin B in paediatric patients with candidaemia or

Neopharm faces uncertain future after 'lacklustre' trial results  -  Apr 5, 2007
In-PharmaTechnologist.com,..."Neopharm has developed two proprietary technology platforms: a tumour-targeting technology and a liposomal drug delivery system called NeoLipid," said

NEOPHARM Provides Update on LE-SN38 Program  -  Mar 30, 2007
American Digital Networks (press release),...but not limited to the Company's ability to develop a program for commercializing LE-SN38 and its other liposomal technology drug product candidates,

DJ DGAP-Adhoc: Sanochemia Pharmazeutika AG receives regulatory ...  -  Apr 24, 2007
VisAvis (Pressemitteilung),A liposomal form of galantamine is currently undergoing clinical trials in neuropathic pain. To find out more about Sanochemia visit the company's website

Second case of kala azar detected in city  -  Apr 24, 2007
Mumbai Newsline,...“As the disease is uncommon in Mumbai, it was very difficult to find Liposomal Amphotericin B, an injection that is a must for the treatment of kala azar.

Alnylam Announces Advancement of a New RNAi Therapeutic ...  -  Apr 18, 2007
PipelineReview.com (press release),ALN-VSP01 is formulated using Alnylam's novel liposomal formulation technology, which has been used to achieve delivery of siRNAs to cells of the liver and

Data on Telavancin and Micafungin Hold Promise of New Therapeutic ...  -  Apr 2, 2007
PR Newswire (press release),A review of the safety of micafungin compared with liposomal amphotericin B in a large, phase III trial in patients with invasive candidiasis and

IDM Pharma Appoints Edward E. Penhoet, Ph.D to Board of Directors  -  Apr 19, 2007
Genetic Engineering News (press release),Junovan (Mifamurtide) is a liposomal preparation of muramyl tripeptide phosphatidyl ethanoloamine (MTPE) for the treatment of children and adolescents with

Inex Pharmaceuticals Provides Progress Update on Alnylam Collaboration  -  Apr 17, 2007
CNW Telbec (Communiqués de presse),Alnylam has taken an exclusive license to INEX's liposomal delivery technology for the discovery, development, and commercialization of RNAi therapeutics

Data from Investigator-Sponsored Trial of Oncophage(R) Cancer ...  -  Apr 16, 2007
PipelineReview.com (press release),Aroplatin(TM) (L-NDDP), a liposomal, third-generation platinum chemotherapeutic; AG-707, a therapeutic vaccine for the treatment of genital herpes;

Vision Digital Completes Acquisition of Clinicares  -  Apr 16, 2007
Web Services Journal,These channels also improve the penetration of the highest concentration of peptides, vitamin creams, or any other liposomal serums about 1000 times.

Callisto Reports on 2006 and First-Quarter 2007 Clinical and ...  -  Apr 16, 2007
PharmaLive.com (press release),Callisto utilizes a uniform validated reconstitution method that we believe delivers a more uniform liposomal drug product when infused into patients.

Data from Investigator-Sponsored Trial of Oncophage ® Cancer ...  -  Apr 16, 2007
Business Wire (press release),Aroplatin™ (L-NDDP), a liposomal, third-generation platinum chemotherapeutic; AG-707, a therapeutic vaccine for the treatment of genital herpes;

Callisto Reports on 2006 and First-Quarter 2007 Clinical and ...  -  Apr 16, 2007
Earthtimes.orgCallistoutilizes a uniform validated reconstitution method that we believe delivers amore uniform liposomal drug product when infused into patients.

Novosom AG Acquires Exclusive Option for CD40-Targeted Antisense ...  -  Apr 11, 2007
CNW Telbec (Communiqués de presse),Novosom's Smarticles(R) liposomal vectors allow partners to deliver their active substance (siRNA, antisense, decoy etc) inside the cell either for topical

Novosom AG Acquires Exclusive Option for CD40-targeted Antisense ...  -  Apr 11, 2007
PharmaLive.com (press release),Novosom’s Smarticles® liposomal vectors allow partners to deliver their active substance (siRNA, antisense, decoy etc) inside the cell either for topical or

Callisto Pharmaceuticals Announces Patient Dosing in L-Annamycin ...  -  Apr 3, 2007
Drug Newswire (press release),L-Annamycin is administered by infusion using a unique patented liposomal formulation. Further details of this trial can be found at www.clinicaltrials.gov.

IDM Pharma Inc. Announces Oncologic Drugs Advisory Committee ...  -  Apr 3, 2007
Business Wire (press release),Junovan (mifamurtide - Liposomal Muramyl Tripeptide Phosphatidyl Ethanolamine MTP-PE) is selectively delivered to macrophages via the scavenger lipoprotein

Data on telavancin and micafungin hold promise of new therapeutic ...  -  Apr 3, 2007
Healthcare Republic...micafungin was associated with efficacy comparable to established treatments, liposomal amphotericin B (L-AmB) and intravenous caspofungin,

Data on Telavancin and Micafungin Hold Promise of New Therapeutic ...  -  Apr 3, 2007
Drug Newswire (press release),...micafungin was associated with efficacy comparable to established treatments, liposomal amphotericin B (L-AmB) and intravenous caspofungin,(9) and that

Nanoparticles For Delivery Of Prostate Cancer Treatment  -  Mar 31, 2007
Medical News Today (press release),With the Prostate Foundation funding Garen will test the efficacy and safety of using targeted liposomal nanoparticle vectors - lipid-covered, gene delivery

Nanoparticles for delivery of prostate cancer treatment  -  Mar 28, 2007
Biology News Net (press release),With the Prostate Foundation funding Garen will test the efficacy and safety of using targeted liposomal nanoparticle vectors — lipid-covered, gene delivery

Aradigm Revisited: CEO Adds Input to Analysis  -  Mar 29, 2007
Seeking Alpha,In unpartnered programs, the lead drug for Aradigm is ARD-3100 or LipoCipro, a liposomal reformulation of ciprofloxacin, aimed at cystic fibrosis.

Market Report -- In Play (CLN)  -  Mar 23, 2007
MSN Money...(Thermally Sensitive Liposomal Doxorubicin) in combination with radiofrequency ablation to treat patients with non-resectable Hepatocellular Carcinoma.

NeoPharm Reports Fourth-Quarter and Full-Year 2006 Financial ...  -  Mar 14, 2007
PharmaLive.com (press release),LE-SN38 is a liposomal formulation of SN-38; the active metabolite of irinotecan, or Pfizer's Camptosar(R), a chemotherapeutic pro-drug used in the

NeoPharm Announces Fiscal 2006 Conference Call and Update on ...  -  Mar 2, 2007
PharmaLive.com (press release),The Company's oncology portfolio is built on two novel, proprietary platforms: a tumor-targeting platform, and the NeoLipid(R) Liposomal Drug Delivery

Nanomolecular Imaging at Johns Hopkins University  -  Mar 22, 2007
Institute for NanoBioTechnology,For example, Dr. George Sgouros, a Professor in the Department of Radiology at JHU, has been using liposomal nanoparticles for targeted delivery of a

INEX and Alnylam Announce Allowance of New US Patent Covering ...  -  Mar 7, 2007
CNW Telbec (Communiqués de presse),..."Our broad and significant collaboration with Alnylam formed just this past January unites INEX's leadership in liposomal delivery technology with Alnylam's

Orphan Drug Approvals: Gestiva, Onconase, Aerosolized Ciprofloxacin  -  Feb 26, 2007
Medscape (subscription)On January 16, the FDA approved orphan drug designation for an inhaled liposomal formulation of ciprofloxacin (made by Aradigm Corp) in the management of

Generic Drug Makers Can Afford FDA User Fees  -  Mar 20, 2007
American Enterprise Institute,...in new areas of generic drug development such as liposomal drugs, certain dermatological creams, and inhaled drugs such as metered dose inhalers.

DGAP-News: Sanochemia Pharmazeutika AG: Results for the FY 2005/06 ...  -  Mar 20, 2007
Financial.de,The company's new development projects, such as the liposomal galantamine formulation (Phase IIa data due shortly) and PVP hypericin (bladder cancer

Tracon Licenses D93 Antibody From Micromet  -  Mar 18, 2007
BioWorld Online,Preclinical work also is ongoing with TRC101, a liposomal encapsulation of Taxotere (docetaxel, Sanofi-Aventis Group) and ceramide, an apoptotic factor

Buy Sun Pharmaceutical: CLSA  -  Mar 16, 2007
Moneycontrol.com,Sun has been investing in R&D over the years and has developed several firsts among Indian companies – eg, Lupron depot, liposomal delivery systems.

Velcade® Safe and Effective for Patients with Multiple Myeloma and ...  -  Mar 15, 2007
Cancer Consultants (press release),...stem cells and the development of new agents such as Thalomid® (thalidomide), Revlimid® (lenalidomide), Doxil® (liposomal doxorubicin) and Velcade.

Brian Corvese Joins Antigenics' Board of Directors  -  Mar 14, 2007
PR-Inside.com (Pressemitteilung),Aroplatin(TM) (L-NDDP), a liposomal, third-generation platinum chemotherapeutic; AG-707, a therapeutic vaccine for the treatment of genital herpes;

Aradigm Focuses on Inhaled Drugs  -  Mar 9, 2007
Seeking Alpha,In unpartnered programs, the lead drug for Aradigm is ARD-3100 or LipoCipro, a liposomal reformulation of ciprofloxacin, aimed at cystic fibrosis.

Callisto Pharmaceuticals Announces Patient Dosing In L-Annamycin ...  -  Mar 9, 2007
Medical News Today (press release),L-Annamycin is administered by infusion using a unique patented liposomal formulation. Further details of this trial can be found at

Vision Digital Multimedia Corporation Completes Acquisition of ...  -  Mar 8, 2007
Newswire Today (press release),These channels also improve the penetration of Oxygenating Hexa Peptides 3 (Oxy3 Peptide), vitamin creams, or any other liposomal serums about 1000 times.

Callisto Pharmaceuticals Announces Patient Dosing in L-Annamycin ...  -  Mar 8, 2007
PharmaLive.com (press release),L-Annamycin is administered by infusion using a unique patented liposomal formulation. Further details of this trial can be found at www.clinicaltrials.gov.

Callisto Pharmaceuticals Announces Patient Dosing in L-Annamycin ...  -  Mar 7, 2007
Earthtimes.orgL-Annamycin isadministered by infusion using a unique patented liposomal formulation.Further details of this trial can be found at www.clinicaltrials.gov.

ProNAi and Novosom AG Announce Collaboration to Enable Delivery of ...  -  Mar 7, 2007
PipelineReview.com (press release),Novosom's Smarticles® liposomal vectors allow partners to deliver their active substance (siRNA, antisense, decoy etc) inside the cell either for topical or

ProNAi and Novosom AG Announce Collaboration to Enable Delivery of ...  -  Mar 6, 2007
PharmaLive.com (press release),Novosom’s Smarticles® liposomal vectors allow partners to deliver their active substance (siRNA, antisense, decoy etc) inside the cell either for topical or

ProNAi and Novosom AG Announce Collaboration to Enable Delivery of ...  -  Mar 6, 2007
PharmaLive.com (press release),Novosom's Smarticles(R) liposomal vectors allow partners to deliver their active substance (siRNA, antisense, decoy etc) inside the cell either for topical

Medical Management of Patients With Head and Neck Cancer  -  Mar 1, 2007
Medscape (subscription)Wang D, Tang C, Ho B, Srivatsan E, Wang M. Liposomal curcumin suppresses growth of head and neck squamous cell carcinoma. Program and abstracts of the 2007

Aradigm gets US FDA orphan drug status for liposomal ciprofloxacin ...  -  Feb 8, 2007
Therapeutics Daily (subscription) (press release),...(ARDM) has received orphan drug designation from the US Food and Drug Administration (FDA) for an inhaled liposomal formulation of ciprofloxacin for the

Newly-Published Study Shows CAELYX(R) Plus Carboplatin to Be ...  -  Feb 16, 2007
netPR.pl (komunikaty prasowe),...(NYSE: SGP) announced today the publication of a multicentre phase II clinical trial that found treatment with CAELYX(R) (pegylated liposomal doxorubicin

Sanochemia Pharmazeutika AG  -  Feb 5, 2007
Ad-Hoc-News (Pressemitteilung),In a multicentric, double-blind, placebo controlled clinical trial, this new liposomal gel formulation was also evaluated for safety and tolerability.

Encore says anesthetic provides effective relief  -  Jan 31, 2007
Pharmaceutical Business ReviewETI-211 consists of a proprietary non-liposomal phospholipid gel (PG) that incorporates the drug forming a single-phase depot system.

Newly-Published Study Shows CAELYX(R) Plus Carboplatin to Be ...  -  Feb 15, 2007
Drug Newswire (press release),CAELYX is a long-circulating pegylated liposomal formulation of doxorubicin hydrochloride, a widely used cytotoxic agent. Cytotoxic agents are designed to

DGAP-News: Sanochemia Pharmazeutika AG: Q1 report / revenues rise ...  -  Feb 22, 2007
Frankfurter Allgemeine Zeitung,Liposomal galantamine and PVP hypericin remain the company's most promising development projects for out-licensing. A central focus of activities in the

Callisto Pharmaceuticals Opens L-Annamycin Phase I Clinical Trial ...  -  Feb 23, 2007
Medical News Today (press release),L-Annamycin is administered by infusion using a unique patented liposomal formulation. Further details of this trial can be found at

Callisto Pharmaceuticals Opens L-Annamycin Phase I Clinical Trial ...  -  Feb 22, 2007
PharmaLive.com (press release),L-Annamycin is administered by infusion using a unique patented liposomal formulation. Further details of this trial can be found at www.clinicaltrials.gov.

Doxil®/Paraplatin® Effective in Recurrent Ovarian Cancer  -  Feb 21, 2007
Cancer Consultants (press release),According to an article recently published in the Annals of Oncology, treatment consisting of Doxil® (pegylated liposomal doxorubicin) and Paraplatin®

Antigenics Reports Fourth Quarter and Year-End 2006 Financial Results  -  Feb 21, 2007
PharmaLive.com (press release),Aroplatin(TM) (L-NDDP), a liposomal, third-generation platinum chemotherapeutic; AG-707, a therapeutic vaccine for the treatment of genital herpes;

Nanoparticle Boost for Antitumor Vaccines  -  Feb 19, 2007
Nanotechwire.com,This work is detailed in a paper titled, “Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of

Possible Cure For Autism  -  Feb 19, 2007
SlashdotThe next obvious problem is that if we indeed have a single liposomal storage disease causing most or all autism, you would find it with brain biopsy and/or

DGAP-News: Sanochemia Pharmazeutika AG: European patent awarded ...  -  Feb 14, 2007
Frankfurter Allgemeine Zeitung,A liposomal form of galantamine is currently in clinical trials for the indication neuropathic pain. To learn more about Sanochemia please visit the

Use of DPI to Determine the Orientation of Membrane Proteins in ...  -  Feb 12, 2007
AZoNano.com,The two liposomal suspensions were flowed, one per channel, over a lipid-enabled AnaChip™ at a rate of 50µlmin -1 . Monitoring of protein binding: The lipid

Nanoparticle boost for antitumor vaccines  -  Feb 12, 2007
Nanowerk LLC,In the current study, the results of which were published in the journal Cancer Immunology and Immunotherapy ("Encapsulation in liposomal nanoparticles

Millennium Exceeds Non-GAAP Profitability Goal and Narrows GAAP ...  -  Feb 8, 2007
PR Newswire (press release),0.0001) in patients receiving VELCADE in combination with DOXIL(R) (pegylated liposomal doxorubicin) compared to in patients receiving VELCADE alone.

Millennium Exceeds Non-GAAP Profitability Goal and Narrows GAAP ...  -  Feb 8, 2007
Yahoo! News (press release)...(p < 0.0001) in patients receiving VELCADE in combination with DOXIL® (pegylated liposomal doxorubicin) compared to in patients receiving VELCADE alone.

Clinical Trial Evaluating Myocet® for Breast Cancer Enrolling Patients  -  Feb 5, 2007
Cancer Consultants (press release),A Phase III clinical trial (last phase prior to FDA review) evaluating the investigative chemotherapy agent Myocet® (liposomal encapsulated doxorubicin) in

Cancer Research Technology grants Waypharm option to novel ...  -  Feb 5, 2007
News-Medical.net,Waypharm will use its formulation expertise and recently accredited production facilities outside of Paris, to optimise a liposomal formulation for entry

Alnylam Presents Pre-clinical Results from Hypercholesterolemia ...  -  Feb 2, 2007
PipelineReview.com (press release),...were presented on ALN-PCS01, Alnylam's RNAi therapeutic targeting PCSK9 which comprises an optimized siRNA formulated in a liposomal nanoparticle.

Alnylam Presents Pre-clinical Results from Hypercholesterolemia ...  -  Feb 1, 2007
Business Wire (press release),...were presented on ALN-PCS01, Alnylam’s RNAi therapeutic targeting PCSK9 which comprises an optimized siRNA formulated in a liposomal nanoparticle.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional